Blog / Archives
Healthcare Stocks Lag Market on Drug Pricing…Update-2
Update-2... 945 am EDT...Biotechs Hold Support IBB up 1.55% to $285 holding support at $280; XBI up 2.99% to $61.95 holding support at $60. Update-1...More Fallout from Mylan (MYL) EpiPen Drug...
Biotech Investors Stung By Drug Pricing Flap…Update-1
Update-1... IBB Trying to hold the $280 line after media bashing of EpiPen Pricing- now they have a generic EpiPen for half the price! Biotech outflows are a concern (-$184M) Gilead Sciences (GILD)...
Pfizer (PFE) Acquisition of Medivation (MDVN) Provides Support to Biotech Stocks…Update-1 IBB Down 3.36%
Update-1 After Close 8/24 IBB at 286.23 XBI down 4.34% XLV down 1.54%, NASDAQ down 0.81% Early Afternoon Reversal Kills Biotech Rally In Heavy Trading But Mylan is not a biotech Company?? The broad...
Today’s Movers in Life Sciences-Gene Sequencing: ILMN,PACB
Illumina (ILMN) Up 3 % to $174 on Buyout Speculation in Gene Sequencing Illumina, Inc. (ILMN) was up as much as 12 points earlier today on a rumored buyout from Thermo Fisher Scientific Inc. (TMO)....
Large Cap Biopharmaceutical Metrics: Valuation Models for Future Growth
Large Cap Biopharmaceutical Valuation Models Can Biotech Growth Re-accelerate in Q4? We reviewed large cap biotech stocks on July 3 just after the BREXIT bottom but prior to Q2 earnings and on May 8...
Biotech Breakout Part 2: Hold Your Fire…Update 8/15/16
Update August 15 : Biotech Leads But Healthcare Sector Lags IBB up 0.92% to $295, XBI up 1.33% to $63.35, XLV up 0.17% to $74.91 The tape was pretty decent despite a quiet day with ALXN up 1.97%,...
Biotech Breakout: Is the Bull Market Back?…Update-1 IBB,BMY
8/5 After the Close... NASDAQ Up 1.06% The IBB inched up 0.38% to $297.29 while the more volatile XBI did better up 1.07%. Both are still down YTD and trail the QQQ which is up 4.39% YTD. Investors...
Biotech Stocks Strike a Bullish Tone: BLUE, IBB, REGN, SGEN…Update-2
Bullish Tone-Large Cap Biopharmaceutical Earnings Updates 8/5 Regeneron (REGN) shares fell another 2.4% to $423 despite a jump of 23% on Eylea sales to $832M compared to $655 M in the prior-year...
Biotechs Get a Turbo Boost from Biogen(BIIB)…Update-1 GILD
Update-1... Gilead Sciences (GILD) Sells Off on earnings Gilead Sciences (GILD) sold off over 4% after hours after releasing second quarter sales of $7.7B and earnings of $3.08/sh. Q2 profit...
Biotech Bear Market Rally: Can Active Funds Beat the ETFs?
Biotech Bear Market Rally Headed Toward Triple Top The biotech rally has wobbly legs moving briskly from the Brexit lows but with choppy action recently.This would be the third time biotech stocks...